glp 1 drugs how long have they been around GLP-1 and Type Diabetes: Less Insulin, Better Time in Range — What the Evidence GLP-1 medications get at the
Description
Finally, one can foresee a future where combination therapy becomes common: for example, a patient with diabetes and obesity might be on both a GLP-1 RA and an SGLT2 inhibitor (for complementary weight loss and cardio-renal protection, which is already done)

The test is used to assess the risk of fetal chromosomal abnormalities such as Down Syndrome (Trisomy 21), Edwards Syndrome (Trisomy 18), and Neural Tube Defects (NTDs)

TABLE 1 Classification and usage of GLP-1RAs

our study demonstrated that combination therapy was associated with a 55% reduction in mortality

For years, obesity rates in the US have gone in one direction: up
2,3,4,5 GLP-1 drugs illustrate the challenging tradeoffs inherent in healthcare access and cost
